Beresford, Mark
Casbard, Angela
Hudson, Zoe
Carucci, Margherita
Ingarfield, Kate
Gee, Julia
Smith, Joanna
Kitson, Terri
Alchami, Fouad
Madden, Tracie-Ann
Hayward, Larrie
Hwang, David
Spensley, Saiqa
Waters, Simon
Wheatley, Duncan
Jones, Robert H.
Funding for this research was provided by:
AstraZeneca
Article History
Received: 23 May 2023
Revised: 11 August 2023
Accepted: 21 August 2023
First Online: 14 September 2023
Competing interests
: The authors declare no competing interests.
: The study was performed in accordance with the principles of Good Clinical Practice, the Declaration of Helsinki, and UK clinical trial regulations and was approved by an independent ethics committee (Wales REC3 committee, UK—Ref. 14/WA/1219). A trial steering committee supervised the study conduct, and an independent data review committee reviewed accumulating accrual, safety, and treatment data at regular intervals, however, there were no formal stopping guidelines. Patients were required to give informed consent prior to undergoing any trial-specific procedure.
: Not applicable.